Centre of Cardiovascular Research and Education in Therapeutics (CCRET), Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia.
Intern Med J. 2014 May;44(5):471-7. doi: 10.1111/imj.12405.
Guidelines for patients with ST-elevation myocardial infarction include a door-to-balloon time (DTBT) of ≤90 min for primary percutaneous coronary intervention.
The aim of this study was to assess temporal trends (2006-2010) in DTBT and determine if a reduction in DTBT was associated with improved clinical outcomes.
We compared annual median DTBT in 1926 STEMI patients undergoing primary percutaneous coronary intervention from the Melbourne Interventional Group registry. ST-elevation myocardial infarction presenting >12 h and rescue percutaneous coronary intervention was excluded. Major adverse cardiac events were analysed according to DTBT (dichotomised as ≤90 min vs >90 min). A multivariable analysis for predictors of mortality (including DTBT) was performed.
Baseline demographics, clinical and procedural characteristics were similar in the STEMI cohort across the 5 years, apart from an increase in out-of-hospital cardiac arrest (3.6% in 2006 vs 9.4% in 2010, P < 0.0001) and cardiogenic shock (7.7-9.6%, P = 0.07). The median DTBT (interquartile range) was reduced from 95 (74-130) min in 2006 to 75 (51-100) min in 2010 (P < 0.01). In this period, the proportion of patients achieving a DTBT of ≤90 min increased from 45% to 67% (P < 0.01). Lower mortality and major adverse cardiac event rates were observed with DTBT ≤90 min (all P < 0.01). Multivariable analysis showed that a DTBT of ≤90 min was associated with improved clinical outcomes at 12 months (odds ratio 0.48; 95% confidence interval 0.33-0.73, P < 0.01).
There has been a decline in median DTBT in the Melbourne Interventional Group registry over 5 years. DTBT of ≤90 min is associated with improved clinical outcomes at 12 months.
ST 段抬高型心肌梗死(STEMI)患者的指南包括行直接经皮冠状动脉介入治疗(PPCI)的门球时间(DTBT)应≤90 分钟。
本研究旨在评估 DTBT 的时间趋势(2006-2010 年),并确定 DTBT 缩短是否与临床结局改善相关。
我们比较了墨尔本介入组注册中心接受直接 PPCI 的 1926 例 STEMI 患者的年度中位数 DTBT。排除 ST 段抬高心肌梗死发病超过 12 小时和补救性经皮冠状动脉介入治疗。主要心脏不良事件根据 DTBT 进行分析(分为≤90 分钟与>90 分钟)。对包括 DTBT 在内的死亡率预测因素进行了多变量分析。
在 5 年期间,STEMI 患者的基线人口统计学、临床和手术特征除院外心脏骤停(2006 年 3.6%,2010 年 9.4%,P<0.0001)和心源性休克(7.7-9.6%,P=0.07)发生率增加外,其余均相似。中位数 DTBT(四分位距)从 2006 年的 95(74-130)分钟减少至 2010 年的 75(51-100)分钟(P<0.01)。在此期间,达到 DTBT≤90 分钟的患者比例从 45%增加到 67%(P<0.01)。DTBT≤90 分钟的死亡率和主要心脏不良事件发生率更低(均 P<0.01)。多变量分析显示,DTBT≤90 分钟与 12 个月时临床结局改善相关(比值比 0.48;95%置信区间 0.33-0.73,P<0.01)。
在 5 年期间,墨尔本介入组注册中心的中位数 DTBT 有所下降。DTBT≤90 分钟与 12 个月时的临床结局改善相关。